Moceri will be presented with the award on Wednesday, Nov. 15, during the 2023 SIA Honors Night reception – and will accept it on behalf of Convergint colleagues around the world.
Northwestern Medicine scientists report results of the first in-human clinical trial in which they used a novel, skull-implantable ultrasound device to open the blood-brain barrier and repeatedly permeate large, critical regions of the human brain to deliver chemotherapy that was injected intravenously.
Northwestern Medicine scientists report results of the first in-human clinical trial in which they used a novel, skull-implantable ultrasound device to open the blood-brain barrier and repeatedly permeate large, critical regions of the human brain to deliver chemotherapy that was injected intravenously.
Chemotherapy drug reaches brain in humans for first time scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
A major obstacle to the treatment of glioblastoma, a deadly brain tumor, is the inability of the most potent chemotherapy to cross the blood-brain barrier to reach aggressive brain tumors. But now, scientists at Northwestern Medicine are using a novel ultrasound device that can be implanted in the skull to open the blood-brain barrier […]